Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
50.04
+0.38 (0.77%)
Dec 5, 2025, 4:00 PM EST - Market closed
Hinge Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Hinge Health stock have an average target of 60.07, with a low estimate of 45 and a high estimate of 71. The average target predicts an increase of 20.04% from the current stock price of 50.04.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 5, 2025.
Analyst Ratings
The average analyst rating for Hinge Health stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 7 | 8 | 9 | 9 | 9 | 9 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $61 → $65 | Strong Buy | Maintains | $61 → $65 | +29.90% | Nov 5, 2025 |
| Barclays | Barclays | Buy Maintains $62 → $65 | Buy | Maintains | $62 → $65 | +29.90% | Nov 5, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $70 → $71 | Buy | Reiterates | $70 → $71 | +41.89% | Nov 5, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +29.90% | Oct 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $57 → $67 | Buy | Maintains | $57 → $67 | +33.89% | Sep 23, 2025 |
Financial Forecast
Revenue This Year
585.31M
from 390.40M
Increased by 49.92%
Revenue Next Year
711.65M
from 585.31M
Increased by 21.59%
EPS This Year
0.82
from -0.88
EPS Next Year
1.57
from 0.82
Increased by 90.96%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 609.1M | 776.9M | ||||
| Avg | 585.3M | 711.7M | ||||
| Low | 561.5M | 647.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.0% | 32.7% | ||||
| Avg | 49.9% | 21.6% | ||||
| Low | 43.8% | 10.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.76 | 2.04 | ||||
| Avg | 0.82 | 1.57 | ||||
| Low | -7.37 | 0.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 148.4% | ||||
| Avg | - | 91.0% | ||||
| Low | - | -14.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.